Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Cancer Science|August 31, 2006
Heterogeneous nuclear ribonucleoprotein B1 expression in malignant mesotheliomaAkio Hiraki, Tomoyuki Murakami, Keisuke Aoe, et al.
Pulmonary Medicine|December 23, 2015
Clinical Investigation of Benign Asbestos Pleural EffusionNobukazu Fujimoto, Kenichi Gemba, Keisuke Aoe, et al.
Acta Medica Okayama|August 24, 2011
Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis?Yoshiko Ogata, Keisuke Aoe, Akio Hiraki, et al.
Lung Cancer (Amsterdam, Netherlands)|July 2, 2011
Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cellsHiroyuki Tao, Yusuke Mimura, Keisuke Aoe, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 19, 2007
Aberrant promoter methylation profile in pleural fluid DNA and clinicopathological factors in patients with non-small cell lung cancerHideki Katayama, Akio Hiraki, Keiichi Fujiwara, et al.
Cytokine|October 2, 2012
Association between cytokine removal by polymyxin B hemoperfusion and improved pulmonary oxygenation in patients with acute exacerbation of idiopathic pulmonary fibrosisKeiji Oishi, Yuka Mimura-Kimura, Taku Miyasho, et al.
Cancer Science|November 19, 2015
Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational studyNaoko Sueoka-Aragane, Nobuyuki Katakami, Miyako Satouchi, et al.
Cancer Science|December 8, 2011
Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesotheliomaMasanori Fujii, Nobukazu Fujimoto, Akio Hiraki, et al.
JTO Clinical and Research Reports|September 30, 2021
Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT StudyNobukazu Fujimoto, Morihito Okada, Takashi Kijima, et al.
International Journal of Cancer|February 8, 2007
Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusionHideki Katayama, Akio Hiraki, Keisuke Aoe, et al.
Pageof 11